ConductScience.org, home

Paper2394831

Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Goldberg IJ and 6 others. J Clin Invest, 1990. Cited by 45 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. Papers, record 2394831. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2394831

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.
PubMed
Journal
J Clin Invest
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldberg IJI J
2Holleran SS
3Ramakrishnan RR
4Adams MM
5Palmer RHR H
6Dell RBR B
7Goodman DSD S

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholesterolMajor topic
HypercholesterolemiaMajor topic
LovastatinMajor topic
Adult
Aged
Colestipol
Female
Humans
Male
Metabolic Clearance Rate
Middle Aged
Niacin

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL-21006NHLBI NIH HHSUnited StatesP50HL021006PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14684130A weighted least-squares technique for the analysis of kinetic data and its application to the study of renal xenon washout in dogs and man.Circ Res1973https://conductscience.org/library/papers/4684130PubMed
22562787Identification of a zinc finger protein that binds to the sterol regulatory element.Science1989https://conductscience.org/library/papers/2562787PubMed
34729058The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.J Clin Invest1973https://conductscience.org/library/papers/4729058PubMed
41245596Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans.J Clin Invest1976https://conductscience.org/library/papers/1245596PubMed
5518733The relation of antemortem characteristics to cardiovascular findings at necropsy--The Framingham Study.Atherosclerosis1979https://conductscience.org/library/papers/518733PubMed
67419983Prediction of the parameters of whole body cholesterol metabolism in humans.J Lipid Res1980https://conductscience.org/library/papers/7419983PubMed
76933445Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6933445PubMed
86575399Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6575399PubMed
96668452Cholesterol turnover and metabolism in two patients with abetalipoproteinemia.J Lipid Res1983https://conductscience.org/library/papers/6668452PubMed
106371816Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6371816PubMed
116565710Plasma mevalonate as a measure of cholesterol synthesis in man.J Clin Invest1984https://conductscience.org/library/papers/6565710PubMed
123989391Whole body and tissue cholesterol turnover in the baboon.J Lipid Res1985https://conductscience.org/library/papers/3989391PubMed
1338603015' end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription.Cell1985https://conductscience.org/library/papers/3860301PubMed
144067430Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins.J Lipid Res1985https://conductscience.org/library/papers/4067430PubMed
153853581Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.J Lipid Res1985https://conductscience.org/library/papers/3853581PubMed
163513311A receptor-mediated pathway for cholesterol homeostasis.Science1986https://conductscience.org/library/papers/3513311PubMed
172610723Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.Atherosclerosis1989https://conductscience.org/library/papers/2610723PubMed
182351867
Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
J Lipid Res1990https://conductscience.org/library/papers/2351867PubMed
193746132Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotype.J Lipid Res1986https://conductscience.org/library/papers/3746132PubMed
203464957Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3464957PubMed

See all 33 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
40372435Allosteric regulation of UBIAD1 trafficking from ER to Golgi revealed by chemical genetic screening.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40372435PubMed
38927094Paradoxes: Cholesterol and Hypoxia in Preeclampsia.Biomolecules2024https://conductscience.org/library/papers/38927094PubMed
38319967Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38319967PubMed
35879350Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain.Nat Commun2022https://conductscience.org/library/papers/35879350PubMed
34842525Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1.Elife2021https://conductscience.org/library/papers/34842525PubMed
32188638Schnyder corneal dystrophy-associated UBIAD1 is defective in MK-4 synthesis and resists autophagy-mediated degradation.J Lipid Res2020https://conductscience.org/library/papers/32188638PubMed
30785396Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice.Elife2019https://conductscience.org/library/papers/30785396PubMed
29107682Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase.Semin Cell Dev Biol2018https://conductscience.org/library/papers/29107682PubMed
28982667Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans.Arterioscler Thromb Vasc Biol2017https://conductscience.org/library/papers/28982667PubMed
28694924Statins redux: A re-assessment of how statins lower plasma cholesterol.World J Diabetes2017https://conductscience.org/library/papers/28694924PubMed
27313057Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.J Lipid Res2016https://conductscience.org/library/papers/27313057PubMed
21369428Microbial production and biomedical applications of lovastatin.Indian J Pharm Sci2008https://conductscience.org/library/papers/21369428PubMed
9118584Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.Clin Pharmacokinet1996https://conductscience.org/library/papers/9118584PubMed
8349825Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects.J Clin Invest1993https://conductscience.org/library/papers/8349825PubMed
8199696Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.J Gastroenterol1994https://conductscience.org/library/papers/8199696PubMed
1904356Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1904356PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HMGCR3156PubTator's text mininghttps://conductscience.org/library/genes/3156NCBI Gene
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2394831

GET https://conductscience.org/api/papers/v1/2394831/references?page=2